Tanzania

Tanzania

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3.5 (2.10 - 5) 2017 Survey/reported Tanzania HIV Impact Survey (THIS) 2016-2017, 2018
4.03 (3.06 - 5.16) 2015 Modelled WHO
4.1 (3.20 - 5.40) 2016 Modelled Razavi-Shearer et al, 2018
7.17 (6.59 - 7.79) 2013 Modelled Schweitzer et al, 2015
3.54 (3.43 - 3.66) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.96 (3.85 - 4.08) 2018 Modelled IHME, GBD 2019 (accessed 2022)
4.07 (3.94 - 4.20) 2017 Modelled IHME, GBD 2019 (accessed 2022)
4.31 (4.19 - 4.45) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4.54 (4.40 - 4.70) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4.63 (4.49 - 4.79) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4.79 (4.65 - 4.95) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.97 (4.83 - 5.14) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.14 (4.98 - 5.31) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5.26 (5.10 - 5.45) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.39 (5.23 - 5.57) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.58 (5.41 - 5.76) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.79 (5.62 - 6) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.99 (5.80 - 6.22) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.13 (5.92 - 6.39) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6.27 (6.06 - 6.52) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.45 (6.24 - 6.70) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6.64 (6.40 - 6.92) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6.81 (6.55 - 7.11) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.91 (6.64 - 7.25) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6.98 (6.71 - 7.31) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7.03 (6.76 - 7.37) 1998 Modelled IHME, GBD 2019 (accessed 2022)
7.08 (6.82 - 7.44) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7.13 (6.85 - 7.49) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7.18 (6.89 - 7.56) 1995 Modelled IHME, GBD 2019 (accessed 2022)
7.23 (6.95 - 7.60) 1994 Modelled IHME, GBD 2019 (accessed 2022)
7.29 (7.01 - 7.66) 1993 Modelled IHME, GBD 2019 (accessed 2022)
7.34 (7.06 - 7.72) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7.4 (7.10 - 7.78) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7.45 (7.15 - 7.83) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.84 (3.71 - 3.96) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
1.69 (1.08 - 2.54) 2015 Modelled WHO
0.38 (0.31 - 0.45) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.44 (0.37 - 0.52) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.40 - 0.58) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.51 (0.42 - 0.63) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.45 - 0.64) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.47 - 0.67) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.48 - 0.68) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.49 - 0.69) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.50 - 0.70) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.50 - 0.72) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.52 - 0.75) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.56 - 0.79) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.63 - 0.88) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.73 - 1.01) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.85 - 1.18) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.17 (0.99 - 1.39) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.57 (1.34 - 1.86) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.25 (1.92 - 2.68) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.02 (2.56 - 3.60) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.65 (3.08 - 4.40) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.97 (3.31 - 4.83) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.04 (3.38 - 4.94) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.09 (3.43 - 5.07) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.13 (3.43 - 5.15) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.17 (3.42 - 5.20) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.2 (3.41 - 5.26) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.23 (3.47 - 5.26) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.27 (3.53 - 5.28) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.3 (3.57 - 5.26) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.34 (3.61 - 5.28) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.37 (3.64 - 5.35) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.80 - 1.21) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
2,261,000 (1,755,000 - 3,022,000) 2016 Modelled Razavi-Shearer et al, 2018
2,008,560 (1,948,220 - 2,074,120) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2,096,720 (2,031,400 - 2,163,250) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2,112,220 (2,050,100 - 2,175,430) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2,115,770 (2,052,540 - 2,184,810) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2,190,690 (2,127,620 - 2,258,810) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2,250,130 (2,180,870 - 2,329,510) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2,237,180 (2,169,640 - 2,311,030) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2,253,970 (2,186,890 - 2,328,700) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2,280,920 (2,215,860 - 2,356,700) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2,299,970 (2,231,520 - 2,379,600) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2,294,730 (2,226,370 - 2,376,400) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2,292,980 (2,224,620 - 2,371,030) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2,318,180 (2,251,120 - 2,396,910) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2,350,960 (2,279,800 - 2,434,420) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2,373,750 (2,295,800 - 2,462,870) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2,370,540 (2,289,410 - 2,468,140) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2,362,310 (2,284,310 - 2,455,740) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2,369,550 (2,290,280 - 2,459,920) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2,378,080 (2,293,460 - 2,475,970) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2,374,970 (2,283,240 - 2,480,690) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,349,040 (2,258,260 - 2,461,370) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,307,100 (2,219,500 - 2,416,980) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,263,150 (2,178,060 - 2,373,240) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,217,940 (2,133,490 - 2,328,180) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,172,180 (2,087,490 - 2,282,750) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,126,620 (2,040,590 - 2,238,690) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,081,870 (2,000,920 - 2,186,220) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,037,740 (1,961,500 - 2,139,590) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,994,160 (1,917,180 - 2,095,260) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,951,080 (1,874,160 - 2,051,300) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,908,540 (1,831,880 - 2,004,360) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.82 (1.81 - 4.06) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5.27 (3.75 - 7.15) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5.21 (3.71 - 7.01) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5.15 (3.67 - 7.01) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5.12 (3.68 - 7.01) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5.06 (3.65 - 6.90) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.99 (3.59 - 6.79) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.93 (3.57 - 6.70) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.9 (3.55 - 6.62) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5.06 (3.63 - 6.69) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.86 (3.52 - 6.49) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5.22 (3.84 - 6.93) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5.17 (3.73 - 6.87) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5.11 (3.75 - 6.76) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5.09 (3.75 - 6.74) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.97 (3.65 - 6.53) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5.07 (3.71 - 6.59) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5.04 (3.69 - 6.64) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4.92 (3.56 - 6.53) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4.84 (3.54 - 6.37) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4.73 (3.41 - 6.24) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4.59 (3.27 - 6.11) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4.3 (3.02 - 5.86) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.51 (2.35 - 4.81) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.15 (2.08 - 4.41) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.92 (2.70 - 5.33) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (1.94 - 4.21) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.01 (1.96 - 4.29) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.1 (2.02 - 4.42) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.02 (1.94 - 4.31) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.82 (1.81 - 4.06) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
2,750 2016 Modelled WHO
1,602 (1,027 - 2,303) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1,365 (972 - 1,852) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1,390 (991 - 1,869) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,415 (1,007 - 1,924) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,446 (1,041 - 1,981) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,472 (1,062 - 2,008) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,493 (1,074 - 2,032) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,518 (1,099 - 2,062) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,552 (1,123 - 2,096) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,582 (1,144 - 2,110) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,693 (1,214 - 2,236) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,775 (1,281 - 2,360) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,840 (1,353 - 2,445) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,852 (1,359 - 2,450) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,896 (1,395 - 2,510) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,935 (1,416 - 2,517) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2,001 (1,470 - 2,628) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,977 (1,448 - 2,604) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2,031 (1,472 - 2,696) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2,051 (1,503 - 2,700) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2,058 (1,485 - 2,715) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2,050 (1,462 - 2,729) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,973 (1,388 - 2,691) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,702 (1,140 - 2,331) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,848 (1,272 - 2,511) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,520 (990 - 2,152) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,568 (1,034 - 2,196) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,580 (1,028 - 2,249) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,671 (1,088 - 2,383) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,668 (1,072 - 2,384) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,602 (1,027 - 2,303) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
2 (1 - 3) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 3) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2017 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 6) 2019 Modelled IHME, GBD 2019 (accessed 2022)
25 (19 - 33) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
89 2019 Survey/reported WHO/UNICEF
86 2020 Survey/reported WHO/UNICEF
81 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
2 (1 - 3) 2016 Survey/reported Larney S et al, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
Year of HBV elimination goal
2030
HBV elimination goal
HBV testing policy
Pregnant women
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.54 (1.22 - 1.94) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.54 (1.23 - 1.92) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.53 (1.22 - 1.90) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.52 (1.23 - 1.89) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.51 (1.22 - 1.88) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.22 - 1.87) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.21 - 1.87) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.21 - 1.88) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.49 (1.20 - 1.88) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.20 - 1.88) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.20 - 1.88) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.20 - 1.88) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.51 (1.20 - 1.88) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.51 (1.21 - 1.88) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.51 (1.21 - 1.88) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.52 (1.22 - 1.88) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.52 (1.22 - 1.87) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.52 (1.22 - 1.87) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.51 (1.23 - 1.87) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.51 (1.22 - 1.87) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.51 (1.22 - 1.87) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.51 (1.21 - 1.87) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.21 - 1.87) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.20 - 1.88) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.21 - 1.88) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.21 - 1.88) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.21 - 1.88) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.51 (1.21 - 1.88) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.51 (1.22 - 1.89) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.52 (1.22 - 1.90) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.48 (1.17 - 1.85) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.27 (0.21 - 0.36) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1 2017 Survey/reported Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), 2018
2.7 (0.20 - 7.80) 2014 Modelled Riou et al, 2015
3.2 2019 Modelled Jin et al. 2017
Showing out of
Show more
People living with HIV (PLHIV)
Download
Value (%) Year Type Source
0.5 2017 Survey/reported Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), 2018
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
41.5 (29.40 - 54.40) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
27.7 (22.40 - 33.50) 2011 Survey/reported Bowring AL et al, 2013
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
8.9 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
388,325 (312,885 - 487,534) 1990 Modelled IHME, GBD 2019 (accessed 2022)
398,365 (321,430 - 498,023) 1991 Modelled IHME, GBD 2019 (accessed 2022)
408,914 (329,895 - 510,887) 1992 Modelled IHME, GBD 2019 (accessed 2022)
419,970 (338,426 - 526,709) 1993 Modelled IHME, GBD 2019 (accessed 2022)
431,515 (348,406 - 539,563) 1994 Modelled IHME, GBD 2019 (accessed 2022)
443,624 (356,758 - 556,750) 1995 Modelled IHME, GBD 2019 (accessed 2022)
456,643 (365,733 - 572,420) 1996 Modelled IHME, GBD 2019 (accessed 2022)
470,401 (377,097 - 584,822) 1997 Modelled IHME, GBD 2019 (accessed 2022)
484,651 (389,362 - 602,627) 1998 Modelled IHME, GBD 2019 (accessed 2022)
499,124 (403,038 - 620,134) 1999 Modelled IHME, GBD 2019 (accessed 2022)
513,616 (414,748 - 636,389) 2000 Modelled IHME, GBD 2019 (accessed 2022)
528,250 (427,455 - 652,250) 2001 Modelled IHME, GBD 2019 (accessed 2022)
542,878 (437,747 - 669,081) 2002 Modelled IHME, GBD 2019 (accessed 2022)
557,304 (448,641 - 688,394) 2003 Modelled IHME, GBD 2019 (accessed 2022)
571,421 (458,922 - 707,778) 2004 Modelled IHME, GBD 2019 (accessed 2022)
585,145 (467,794 - 725,485) 2005 Modelled IHME, GBD 2019 (accessed 2022)
598,503 (478,201 - 744,816) 2006 Modelled IHME, GBD 2019 (accessed 2022)
611,521 (488,822 - 760,343) 2007 Modelled IHME, GBD 2019 (accessed 2022)
624,632 (500,667 - 780,042) 2008 Modelled IHME, GBD 2019 (accessed 2022)
638,216 (510,434 - 800,623) 2009 Modelled IHME, GBD 2019 (accessed 2022)
652,729 (522,257 - 822,036) 2010 Modelled IHME, GBD 2019 (accessed 2022)
668,887 (537,630 - 840,543) 2011 Modelled IHME, GBD 2019 (accessed 2022)
686,630 (553,602 - 862,403) 2012 Modelled IHME, GBD 2019 (accessed 2022)
705,913 (570,104 - 881,870) 2013 Modelled IHME, GBD 2019 (accessed 2022)
726,576 (587,764 - 907,035) 2014 Modelled IHME, GBD 2019 (accessed 2022)
748,373 (604,179 - 933,105) 2015 Modelled IHME, GBD 2019 (accessed 2022)
771,976 (623,496 - 960,618) 2016 Modelled IHME, GBD 2019 (accessed 2022)
796,082 (636,208 - 990,199) 2017 Modelled IHME, GBD 2019 (accessed 2022)
819,769 (654,823 - 1,023,030) 2018 Modelled IHME, GBD 2019 (accessed 2022)
843,635 (667,943 - 1,058,090) 2019 Modelled IHME, GBD 2019 (accessed 2022)
837,035 (662,412 - 1,049,910) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
37,100 (28,600 - 49,200) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
5.63 (3.78 - 7.84) 2019 Modelled IHME, GBD 2019 (accessed 2020)
6.85 (5.15 - 8.91) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6.77 (5.08 - 8.76) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6.7 (5.01 - 8.70) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6.64 (4.96 - 8.62) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6.57 (4.87 - 8.52) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6.47 (4.85 - 8.36) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6.34 (4.76 - 8.13) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6.39 (4.83 - 8.19) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6.26 (4.80 - 8.05) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6.57 (5.05 - 8.47) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6.75 (5.17 - 8.64) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6.78 (5.15 - 8.71) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6.86 (5.25 - 8.77) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.8 (5.08 - 8.78) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6.8 (5.07 - 8.70) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.68 (5.01 - 8.60) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.78 (5.04 - 8.73) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6.58 (4.93 - 8.45) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6.44 (4.85 - 8.30) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6.26 (4.70 - 8.11) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6.07 (4.51 - 7.89) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.87 (4.34 - 7.65) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5.81 (4.23 - 7.73) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.65 (3.85 - 7.70) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5.74 (4 - 7.71) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5.8 (4.15 - 7.78) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5.57 (3.80 - 7.65) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5.6 (3.82 - 7.61) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5.6 (3.77 - 7.73) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5.63 (3.78 - 7.84) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,749 2016 Modelled WHO
3,196 (2,145 - 4,449) 2019 Modelled IHME, GBD 2019 (accessed 2022)
3,196 (2,145 - 4,449) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3,093 (2,083 - 4,273) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3,016 (2,055 - 4,099) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2,925 (1,991 - 4,011) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2,889 (1,969 - 3,933) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2,855 (1,987 - 3,838) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2,807 (2,007 - 3,768) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2,740 (1,995 - 3,645) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2,695 (1,990 - 3,510) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2,712 (2,017 - 3,526) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2,726 (2,044 - 3,530) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2,730 (2,059 - 3,518) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2,716 (2,038 - 3,491) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2,688 (2,014 - 3,461) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2,658 (1,974 - 3,423) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2,598 (1,937 - 3,323) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2,530 (1,890 - 3,265) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2,456 (1,868 - 3,157) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2,422 (1,852 - 3,093) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,319 (1,775 - 2,968) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,196 (1,689 - 2,830) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,038 (1,562 - 2,620) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,006 (1,507 - 2,571) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,967 (1,485 - 2,521) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,936 (1,452 - 2,501) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,910 (1,418 - 2,479) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,878 (1,402 - 2,436) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,839 (1,376 - 2,390) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,806 (1,354 - 2,336) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,775 (1,333 - 2,309) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
1 (1 - 2) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1 (1 - 2) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1 (1 - 2) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1 (1 - 2) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1 (1 - 2) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1 (1 - 2) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1 (1 - 2) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1 (1 - 2) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1 (1 - 2) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1 (1 - 2) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1 (1 - 2) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 2018 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 2019 Modelled IHME, GBD 2019 (accessed 2022)
20 (14 - 27) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
2 (1 - 3) 2016 Survey/reported Larney S et al, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
Year of HBV elimination goal
2030
HBV elimination goal
HBV testing policy
Pregnant women
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No

Overview